A Memorandum of Understanding (MOU) is a formal agreement between the Food and Drug Administration (FDA) and federal, state, or local government agencies; academic institutions; and other entities (e.g., non-profit organizations). The MOU constitutes an understanding between the parties but is a non-binding agreement. It is FDA's policy to enter into MOUs with other entities whenever there is a need to define lines of authority or responsibility or to clarify cooperative procedures. The intent of the MOU is to improve consumer protection through more effective use of collective resources and to eliminate duplication of activities.
- For information about agreements between FDA and other governments, please see FDA's Cooperative Arrangements page for more information.
- For a directory of individual Center/Office MOU contacts, please see Agency Contacts for MOUs
Currently, FDA's Acting MOU Program Manager is:
Elizabeth "Betsy" Wiley
Office of the Executive Secretariat